Terasaki PI - Search Results

1

No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study.

Delgado JC, Fuller A, Ozawa M, Smith L, Terasaki PI, Shihab FS, Eckels DD. Delgado JC, et al. Among authors: terasaki pi. Transplantation. 2009 Feb 27;87(4):546-8. doi: 10.1097/TP.0b013e3181949d2e. Transplantation. 2009. PMID: 19307792 Clinical Trial.

2

Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial.

Terasaki PI, Ozawa M. Terasaki PI, et al. Transplantation. 2005 Nov 15;80(9):1194-7. doi: 10.1097/01.tp.0000174338.97313.5a. Transplantation. 2005. PMID: 16314785

3

Predicting kidney graft failure by HLA antibodies: a prospective trial.

Terasaki PI, Ozawa M. Terasaki PI, et al. Am J Transplant. 2004 Mar;4(3):438-43. doi: 10.1111/j.1600-6143.2004.00360.x. Am J Transplant. 2004. PMID: 14961999 Free article.

4

Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.

Deng CT, El-Awar N, Ozawa M, Cai J, Lachmann N, Terasaki PI. Deng CT, et al. Among authors: terasaki pi. Transplantation. 2008 Aug 15;86(3):452-9. doi: 10.1097/TP.0b013e3181804cd2. Transplantation. 2008. PMID: 18698250

5

Predicting operational tolerance in pediatric living-donor liver transplantation by absence of HLA antibodies.

Waki K, Sugawara Y, Mizuta K, Taniguchi M, Ozawa M, Hirata M, Nozawa M, Kaneko J, Takahashi K, Kadowaki T, Terasaki PI, Kokudo N. Waki K, et al. Among authors: terasaki pi. Transplantation. 2013 Jan 15;95(1):177-83. doi: 10.1097/TP.0b013e3182782fef. Transplantation. 2013. PMID: 23232368

6

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.

Everly MJ, Rebellato LM, Haisch CE, Ozawa M, Parker K, Briley KP, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI. Everly MJ, et al. Among authors: terasaki pi. Transplantation. 2013 Feb 15;95(3):410-7. doi: 10.1097/TP.0b013e31827d62e3. Transplantation. 2013. PMID: 23380861

7

The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.

Freitas MC, Rebellato LM, Ozawa M, Nguyen A, Sasaki N, Everly M, Briley KP, Haisch CE, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI. Freitas MC, et al. Among authors: terasaki pi. Transplantation. 2013 May 15;95(9):1113-9. doi: 10.1097/TP.0b013e3182888db6. Transplantation. 2013. PMID: 23514959

8

Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients.

Hata Y, Cecka JM, Takemoto S, Ozawa M, Cho YW, Terasaki PI. Hata Y, et al. Among authors: terasaki pi. Transplantation. 1998 Jan 27;65(2):208-12. doi: 10.1097/00007890-199801270-00011. Transplantation. 1998. PMID: 9458016

9

Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival.

Terasaki PI, Ozawa M, Castro R. Terasaki PI, et al. Am J Transplant. 2007 Feb;7(2):408-15. doi: 10.1111/j.1600-6143.2006.01644.x. Epub 2007 Jan 4. Am J Transplant. 2007. PMID: 17229080 Free article.

10

De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.

Smith JD, Banner NR, Hamour IM, Ozawa M, Goh A, Robinson D, Terasaki PI, Rose ML. Smith JD, et al. Among authors: terasaki pi. Am J Transplant. 2011 Feb;11(2):312-9. doi: 10.1111/j.1600-6143.2010.03383.x. Epub 2011 Jan 10. Am J Transplant. 2011. PMID: 21219570 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

867 results

Search Page

Filters